抗生素管理工作(英文ppt)antibiotic stewardship课件

上传人:bin****86 文档编号:56115442 上传时间:2018-10-09 格式:PPT 页数:44 大小:140KB
返回 下载 相关 举报
抗生素管理工作(英文ppt)antibiotic stewardship课件_第1页
第1页 / 共44页
抗生素管理工作(英文ppt)antibiotic stewardship课件_第2页
第2页 / 共44页
抗生素管理工作(英文ppt)antibiotic stewardship课件_第3页
第3页 / 共44页
抗生素管理工作(英文ppt)antibiotic stewardship课件_第4页
第4页 / 共44页
抗生素管理工作(英文ppt)antibiotic stewardship课件_第5页
第5页 / 共44页
点击查看更多>>
资源描述

《抗生素管理工作(英文ppt)antibiotic stewardship课件》由会员分享,可在线阅读,更多相关《抗生素管理工作(英文ppt)antibiotic stewardship课件(44页珍藏版)》请在金锄头文库上搜索。

1、Antibiotic Stewardship,C.G. Wlodaver, M.D.,Agenda,Basics Specifics Physician/administration acceptance Physician response Measurement/reporting Cost implications Clinical vignettes and user friendly recommendations,Goal,Condense clinical infectious disease ad absurdum Create mini-ID specialists, by

2、recipe,What is Antibiotic Stewardship?,A program that encourages judicious (vs injudicious) use of antibiotics Antibiotics are relatively so effective, non-toxic and inexpensiveso easy to usethat they are prone to abuse When the diagnosis is uncertain, antibiotics are often prescribed Stewardship st

3、rives to fine tune antibiotic Rx in regards to Efficacy Toxicity Resistance-induction C. difficile-induction Cost Discontinuation,How does it relate to MRSA?,Resistance-induction: MRSA and other MDRSs Darwinism Flemming Weinstein, L Native American wisdom Efficacy Some prescribers are still in the M

4、SSA era,What are its limitations?,Its difficult/dangerous to practice clinical infectious diseases with limited information Select cases very carefully Primum non nocere,Does it work?,Data.,Recommended by,Collaborative Drs. Perl, Bratzler, CW IDSA Practiced regularly,How does it work?,A pharmacist,

5、par excellence, or someone else reviews patients on antibiotics and makes recommendations, prn; overseen by ID-trained physician, when available. Training Physician contacted Telephone call Notation in chart Rx change written Pharmacist, verbal order Physician,Common Interventions Some are so eviden

6、t that they should be automatic,Allergy Efficacy Empiric, vs MRSA Based on culture and sensitivity Dosing Cefazolin, q8h Ceftriaxone, q24h Levels Vancomycin Aminoglycosides,IV-to-po switch Criteria Afebrile WBC normalized Oral bio-availability, e.g. quinolones. Intact GI tract Patient can often go h

7、ome on po without further in-hospital observation,Redundancy E.g. Unasyn or Zosyn + Flagyl,When to discontinue antibiotics altogether!,Asymtomatic UTI Viral URI Exacerbation of COPD? CHF misdiagnosed as pneumonia CoNS bacteremia, when contamination more likely than true infection Duration: criteria

8、to d/c,Asymtomatic UTI,Definition: pyuria/bacteriuria, without Sx, e.g. temperature and WBC WNL Common Data,Viral URI,How do you know its viral and not bacterial?,Exacerbation of COPD,How do you know if its bacterial? Antibiotics not unreasonable. 5 days should suffice,CHF misdiagnosed as pneumonia,

9、How do you distinguish one from the other? H&P, temperature, WBC, CXR, BNP, cultures (sputum and blood), pneumococcal urine antigen If antibiotics started and continued, 5 days should suffice,CoNS bacteremia,How do you know if its real or contamination? Real Hospitalized, IV (phlebitis), fever, leuk

10、ocytosis, multiple positive cultures Contamination Present on admission/no IV, no fever, no leukocytosis, few positive cultures/denominator,Duration: Criteria to d/c antibiotics,Evidence-based Infectious endocarditis, osteomyelitis (Dont streamline!),Uncomplicated UTI,Community-acquired pneumonia,Ho

11、spital-acquired pneumonia,Empiric discontinuation Once temperature and WBC have normalized,Additional recommendations,SCIP C.difficile Pneumonia MRSA furunculosis Therapeutic substitutions,SCIP,Antibiotic prophylaxis Which agent? Function of most common pathogen(s) Staph. aureus First generation cep

12、halosporin If PCN-allergic If high prevalence of MRSA Anaerobes Cefoxitin When to start? 1 hour pre-op. When to stop? 1 dose only Within 24 hours,Clostridium difficile,Use guidelines,Community-acquired pneumonia,Use guidelines,MRSA furunculosis,I&D may suffice, without antibiotics,Therapeutic Substi

13、tutions,Quinolones Cephalosporins,Physician/administration Acceptance,Medical Executive Committee approval! Letter to physicians CW.,Physician Response,Bell-shaped curve Dr. S Dr. D Antibiotics viewed as “drugs of fear” Fear of omission Law suits Fear of commission Law suits,Measure Interventions,#

14、patients reviewed # physicians contacted (interventions recommended/ # patients reviewed: % # interventions accomplished/ # recommended: % Change to avoid allergic reaction Drug-drug interactions addressed Change to different antibiotic based on C&S Changed dose IV-to-po switch Antibiotics discontin

15、ued altogether,C. difficile rate MRSA rate,Bad outcomes, viz. patient suffered because of an antibiotic-deficiency,Reporting Measurements,Hospital P&T Committee Infection Control Committee Medical Executive Committee MRSA Collaborative Federal Agencies JCAHO CMS,Cost Implications,Its the right thing

16、 to do, regardless of cost Antibiotic costs Pharmacy Administration Personnel Pharmacist ID or other MD oversight Self-perpetuating,BREAK,Vignettes,Asymtomatic UTI,An 83 yo woman suffers from dementia and resides in a nursing home. The NH staff is concerned about her increased confusion and decides

17、to send her to the local ER. VS: BP 140/90, P 90, RR 16, T 98.6. PE WNL except for mild confusion. No Foley. WBC 10.1. U/A 5-10 WBC/hpf. Dx: “UTI.” Rx Avelox. The following day her urine culture returns with E.coli, 100K. Avelox continued x 1 wk. She becomes more confused, develops C.diff antibiotic-associated colitis and expires.,

展开阅读全文
相关资源
相关搜索

当前位置:首页 > 办公文档 > PPT模板库 > 其它

电脑版 |金锄头文库版权所有
经营许可证:蜀ICP备13022795号 | 川公网安备 51140202000112号